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ABSTRACT 
Kasa is one of the commonest complaints in day to day pediatric practice and it is also a symptom of various diseases of respiratory system. Recurrent 
attacks makes the school going child suffer and may have its adverse effects on the studies of the child. The present clinical study was carried out to 
evaluate the effect of syrup Shati compound in Vataja kasa in children. The clinical trial was conducted on 73 patients in between the age group of 2 
to 10 years. They were divided into two groups; each group consisted of minimum 30 patients. Group A and Group B were given syrup Shati 
compound and placebo concentrated sugar solution respectively. The results were analysed statistically. The analysis suggested that the syrup Shati 
compound is effective and safe herbal formulation in reducing the signs and symptoms of Vataja kasa. 
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INTRODUCTION 
As  a  known  fact  Uchhwasa  and  Nishwasa  or  to  say 
breathing in and breathing out, is the normal phenomenon 
of life. To and fro movement of air through the Pranavaha 
srotas  is  the  vital  sign  of  life,  the  normalcy  of  which 
suggests health.
 The abnormality in respiration indicates 
disease and its cessation marks death. This unique sign of 
life is  affected in the disease  Kasa.  Kasa is one  of the 
commonest  complaints  in  day  to  day  pediatric  practice 
and it is also a symptom of various diseases of respiratory 
system. Kasa may not be life threatening but increasingly 
annoying  and  irritating  to  individuals  in  their  routine 
activities.  Moreover  when  neglected  it  may  lead  to  a 
series  of  complications.  Kasa  has  a  broad  spectrum  of 
etiology, ranging from allergens to infections. Recurrent 
attacks makes the school going child suffer and may have 
its  adverse  effects  on  the  studies  of  the  child.  Cough 
occurs  in  association  with  acute  upper  respiratory 
infection, acute pharyngitis, acute bronchitis and chronic 
sinusitis, all of which rank among the top 10 reasons for 
visiting family physicians. 
Shamana  line  of  treatment  that  includes  oral 
administration of medicine is of utmost importance as the 
administration is very easy and also effective compared to 
Shodhana  in  children.  Many  research  works  have  been 
carried  out  in  relation  to  the  Shamana  treatment  as 
directed  in  Ayurveda  and  their  therapeutic  effects  are 
proved.  Many  herbal  combinations  are  described  in 
Ayurveda and their therapeutic effect in Kasa is yet to be 
explored.  The  effect  of  syrup  of  an  indigenous  drug 
compound containing equal quantities of Shati
1 and stem 
bark of Badara
2 is likely to be very effective in combating 
the signs and symptoms of Vataja Kasa
3-5. 
A  Clinical  Study  on  Kasa  with  an  Indigenous  drug 
Compound
6 was also reported. 
 
 
 
MATERIALS AND METHODS 
Present  study  was  being  carried  out  for  scientific 
understanding of a folklore claim of this trial drugs like 
Shati  and  Badara  Twak  in  the  management  of  Vataja 
Kasa.  The  present  study  was  conducted  on  children  of 
Vataja Kasa in between the age group of 2 to 10 years. 
Patients were divided into two groups. Group A and B 
were treated with syrup Shati compound which contains 
combination of Shati and Badara Twak and syrup sugar 
solution  respectively  which  were  prepared  at  SDP 
Ayurveda Pharmacy Puttur, D.K., India. The observations 
of  the  cases  were  recorded  according  to  the  research 
proforma. 
 
Criteria for selection of patients 
Patients with signs and symptoms  of  Vataja  Kasa were 
selected randomly irrespective of their sex, religion etc. 
from  Kaumarabhritya  O.P.D  of  S.D.M.  Ayurvedic 
Hospital,  Hassan,  India.  Institutional  Ethical  Clearance 
Number:  SDM/  IEC/09/2008-2009  was  granted  for  this 
study. 
 
Inclusion Criteria 
·  Patients presenting with Vataja Kasa. 
·  Any  of  two  or  more  symptoms  described  in  the 
context of Vataja Kasa.    
·  Patients of Vataja Kasa with chronicity of less than 15 
days duration.  
·  Patients  irrespective  of  sex,  religion,  socioeconomic 
status and between the age group of 2-10 years were 
taken.          
 
Exclusion Criteria 
·  Other than Vataja  Kasa 
·  Kasa  as  anubhandha  lakshana  in  other  systemic 
diseases.  
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Study Design 
For  diagnostic  purpose  the  signs  and  symptoms 
mentioned below were taken for the study. 
·  Shushka Kasa 
·  Shirashoola 
·  Swarabheda 
·  Parshwa Shoola 
·  Ura Shoola 
·  Shushka vaktra 
·  Kantodhvamsanam 
 
Dose, duration and mode of administration 
·  Duration of the treatment -10 days 
·  Dosage internally – syrup Shati compound 5 ml for 5-
10 years of age group and 2.5 ml for 2 – 5 years of age 
group in QID that is  6
th hourly after food. 
·  Placebo - syrup sugar solution 5 ml for 5-10 years age 
group and 2.5 ml for 2 – 5 years of age group in QID 
that is 6th hourly after food. 
 
Criteria for Assessment 
Children suffering from Vataja Kasa were assessed and 
evaluated on the basis of following parameters. 
·  KasaVega  
·  Duration of each bout  
·  Anidra  
·  Throat congestion 
·  AEC 
 
Statistical Analysis 
Statistical  analysis  was  carried  out  using  the  software 
SPSS 17.0. We performed  frequency calculations along 
with  parametric  and  non-parametric  test  procedures. 
Differences  of  paired  samples  e.g.  comparison  between 
beginning  and  end  of  a  treatment  were  tested  with 
Dependent t test with regard to significance. Differences 
of independent samples were tested via the Independent 
sample t test. 
 
RESULTS AND DISCUSSION 
Syrup  Shati  compound  helps  in  reducing  Shirashoola, 
Parshwa Shoola and Ura Shoola due to Ushna Veerya of 
the drug Shati which acts as Vedana sthapaka. 
Kasa  vega,  Shushka  kasa,  Shushka  vaktra  and  Swara 
bheda are due to Rooksha Guna of Vata and the Snigdha 
guna  of  Badara  might  provide  better  relief  in  those 
symptoms. 
The pungent principles of Shati in syrup Shati compound 
acts  as  a  potent  anti-tussive
7  probably  by  blocking  the 
vagal  sensory  afferents  by  counter  irritant  and  local 
anaesthetic mechanism. 
Table 1: Registration data 
 
Groups  No. of patients 
Total Registered  Drop out  Completed 
Group A: syrup Shati compound  31  1  30 
Group B: syrup Sugar solution  42  12  30 
Total  73  13  60 
 
Table 2: Effect on symptoms, signs and hematological parameters of Vataja Kasa in Group A 
 
Features  N  BT  AT  % of relief  SE  T  P 
Shushka Kasa  30  2.00  0.23  88.89  0.08  22.49  <0.001 
Shirashoola  28  1.00  0  100  0.07  14.75  <0.01 
Swarabheda  29  1.53  0.20  90.23  0.13  10.27  <0.001 
Parshwa Shoola  28  1.0  0  100  0.07  14.75  <0.001 
Ura Shoola  29  1.00  0  100  0.05  20.86  <0.001 
Shushka vaktra  29  1.43  0.23  89.66  0.15  8.16  <0.001 
Kantodhvamsanam  29  1.17  0.07  98.85  0.10  11.0  <0.001 
KasaVega  30  2.07  0.23  90.56  0.07  26.49  <0.001 
Duration of each bout  30  2.10  0.23  91.11  0.06  29.57  <0.001 
Anidra  28  1.17  0.03  100  0.11  9.87  <0.001 
Rhonchi  13  0.53  0  100  0.12  4.29  <0.01 
Throat congestion
  29  0.97  0  100  0.03  29  <0.001 
Total WBC  30  8889.2  8787.6  1.10 ↓  22.23  4.57  <0.001 
Neutrophil (%)  30  66.93  65  2.78 ↓  0.46  4.18  <0.01 
Lymphocyte (%)  30  26.2  31.07  21.45 ↑  1.52  3.2  <0.01 
Eosinophil (%)  30  6.57  5.3  17.42 ↓  0.19  6.62  <0.001 
Monocyte (%)  9  0.3  0.07  88.89 ↓  0.09  2.54  <0.05 
AEC  30  531.13  459.6  12.63 ↓  10.26  6.98  <0.001 
ESR (mm/1
st hr)  30  8.83  5.67  35.76 ↓  0.29  10.85  <0.001 
Hb (gm %)  30  13.84  14.03  1.42  ↑  0.04  4.97  <0.001 
Note: ↓decrease, ↑increase 
N- Number of Frequency, BT- Before Treatment, AT- After Treatment, SE- Standard Error 
T- Value got after applying T Test and P- Probability. 
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Table 3: Effect on symptoms, signs and hematological parameters of Vataja Kasa in Group B 
 
Features  N  BT  AT  % of relief  SE  T  P 
Shushka Kasa  30  2.00  1.53  23.33  0.09  5.04  <0.001 
Shirashoola  19  0.70  0.20  89.47  0.12  4.01  <0.01 
Swarabheda  30  1.73  1.43  13.33  0.10  3.07  <0.01 
Parshwa Shoola  23  0.83  0.77  17.39  0.10  0.70  >0.05 
Ura Shoola  23  0.80  0.97  2.17 ↑  0.08  1.98  >0.05 
Shushka vaktra  30  1.67  1.30  16.67  0.10  3.61  <0.01 
Kantodhvamsanam  30  1.53  1.10  19.44  0.10  4.18  <0.01 
KasaVega (Bouts of cough)  30  2.20  1.63  25  0.09  6.16  <0.001 
Duration of each bout  30  2.17  1.57  24.72  0.09  6.60  <0.001 
Anidra  27  1.27  0.97  25.93  0.12  2.52  <0.05 
Rhonchi  11  0.53  0.30  50  0.09  2.54  <0.05 
Throat congestion
  27  0.93  1.0  7.14↑  0.05  1.44  >0.05 
Total WBC  30  8938.9  8946.77  0.12↑  9.38  0.84  >0.05 
Neutrophil (%)  30  67.93  68.6  1.14↑  0.48  1.40  >0.05 
Lymphocyte (%)  30  25.53  25.10  0.46↓  0.53  0.82  >0.05 
Eosinophil (%)  30  6.37  6.40  0.83↑  0.06  0.57  >0.05 
Monocyte (%)  5  0.17  0  100  0.07  2.41  <0.05 
AEC  30  549.10  550.87  0.75 ↑  2.90  0.61  >0.05 
ESR (mm/1
st hr)  30  8.93  9.07  6.11↑  0.29  0.45  >0.05 
Hb (gm %)  30  12.83  12.62  1.63↓  0.04  4.75  <0.001 
Note: ↓decrease, ↑increase 
N- Number of Frequency, BT- Before Treatment, AT- After Treatment, SE- Standard Error, T- Value got after applying T Test and P- Probability. 
 
Table 4: Comparative effect on symptoms, signs and hematological parameters of Vataja Kasa in Group A and Group B 
 
Measures  Group A  Group B  T  p value 
N  % Relief  N  % Relief 
Shushka Kasa  30  88.89  30  23.33  10.97  < 0.001 
Shirashoola  28  100  19  89.47  2.09  < 0.05 
Swarabheda  29  90.23  30  13.33  10.45  < 0.001 
Parshwa Shoola  28  100.00  23  17.39  12.27  < 0.001 
Ura Shoola  29  100.00  23  2.17 ↑  50.66  < 0.001 
Shushka vaktra  29  89.66  30  16.67  9.60  < 0.001 
Kantodhvamsanam  29  98.85  30  19.44  12.61  < 0.001 
KasaVega (Bouts of cough)  30  90.56  30  25.0  12.31  < 0.001 
Duration of each bout  30  91.11  30  24.72  13.24  < 0.001 
Anidra  28  100.00  27  25.93  12.20  <0.001 
Rhonchi  13  100  11  50  4.67  < 0.001 
Throat congestion
  29  100.00  27  7.14  4.61  <0.001 
Total WBC  30  1.10  30  0.12  4.60  < 0.001 
Neutrophil (%)  30  2.78  30  1.14  3.97  < 0.001 
Lymphocyte (%)  30  21.45  30  0.46  3.08  < 0.01 
Eosinophil (%)  30  17.42  30  0.83  7.28  < 0.001 
Monocyte (%)  9  88.89  5  100  0.73  N.S 
AEC  30  12.63  30  0.75  6.71  < 0.001 
ESR (mm/1
st hr)  30  35.76  30  6.11  7.39  < 0.001 
Hb (gm %)  30  1.42↑  30  1.63↓  6.90  < 0.001 
Note: ↓decrease, ↑increase and N.S not significant 
N- Number of Frequency, T- Value got after applying T Test and P- Probability. 
 
Kashaya Rasa of Badara twak in syrup Shati compound 
does the mucosal modulation which cuts off the contact of 
antigen  and  receptors  such  as  Dendritic  Cells,  MHCs 
those  are  embedded  in  the  mucosa  of  nose,  pharynx, 
larynx  etc.  This  drug  action  explains  the  symptomatic 
relief from Kasa. 
The marked decrease in ESR and simultaneous decrease 
in (Absolute Eosinophil Count) AEC clearly indicates the 
drug’s  action  on  allergic  conditions.  Decrease  in  Total 
counts and polymorphs indicate the drug’s effectiveness 
even in infectious conditions. 
In modern perspective the drugs with pungent taste and 
hot potency such as Shati act as local counter irritants and 
block the efferent fibers of vagus which carry the cough 
stimuli to the cough center
8,9. In addition to this, drug also 
acts as Mucolytic. 
Stem  bark  of  Badara  with  abundant  tannins,  exhibit 
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modulate  them  to  decrease  exudation
10  and  provide  a 
shield  against  the  contact  of  any  antigen,  in  addition 
tannins also have local antimicrobial action which destroy 
the microbes coming in contact. 
 
CONCLUSION 
Kasa being the common childhood ailment has been given 
more  emphasis  by  the  medical  fraternity,  because  it 
diverts  parents  psyche  from  their  routine  work.  On 
clinical symptoms of Vataja Kasa, syrup Shati compound 
provided  relief  in  all  the  cardinal  and  associated 
symptoms  of  Vataja  Kasa.  All  the  changes  were 
statistically highly significant. The syrup Shati compound 
also  showed  statistically  highly  significant  relief  in 
duration  of  each  bout,  frequency  of  bouts,  throat 
congestion, AEC and also show improvement in Hb gram 
%. The findings suggest that syrup Shati compound is an 
effective and safe herbal formulation for the Vataja Kasa. 
 
Abbreviation  
WBC –White Blood Cell count 
Hb –Hemoglobin 
ESR –Erythrocyte Sedimentation Rate 
AEC –Absolute Eosinophil Count 
N.S - Not significant 
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